236 related articles for article (PubMed ID: 26806338)
1. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
Yachida S; Wood LD; Suzuki M; Takai E; Totoki Y; Kato M; Luchini C; Arai Y; Nakamura H; Hama N; Elzawahry A; Hosoda F; Shirota T; Morimoto N; Hori K; Funazaki J; Tanaka H; Morizane C; Okusaka T; Nara S; Shimada K; Hiraoka N; Taniguchi H; Higuchi R; Oshima M; Okano K; Hirono S; Mizuma M; Arihiro K; Yamamoto M; Unno M; Yamaue H; Weiss MJ; Wolfgang CL; Furukawa T; Nakagama H; Vogelstein B; Kiyono T; Hruban RH; Shibata T
Cancer Cell; 2016 Feb; 29(2):229-40. PubMed ID: 26806338
[TBL] [Abstract][Full Text] [Related]
2. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.
Mesquita B; Lopes P; Rodrigues A; Pereira D; Afonso M; Leal C; Henrique R; Lind GE; Jerónimo C; Lothe RA; Teixeira MR
Breast Cancer Res Treat; 2013 Feb; 138(1):37-45. PubMed ID: 23329352
[TBL] [Abstract][Full Text] [Related]
3. Defining the Molecular Alterations of Ampullary Carcinoma.
Tan J; Tan P; Teh BT
Cancer Cell; 2016 Feb; 29(2):135-6. PubMed ID: 26859450
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
5. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
6. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
Gingras MC; Covington KR; Chang DK; Donehower LA; Gill AJ; Ittmann MM; Creighton CJ; Johns AL; Shinbrot E; Dewal N; Fisher WE; ; Pilarsky C; Grützmann R; Overman MJ; Jamieson NB; Van Buren G; Drummond J; Walker K; Hampton OA; Xi L; Muzny DM; Doddapaneni H; Lee SL; Bellair M; Hu J; Han Y; Dinh HH; Dahdouli M; Samra JS; Bailey P; Waddell N; Pearson JV; Harliwong I; Wang H; Aust D; Oien KA; Hruban RH; Hodges SE; McElhany A; Saengboonmee C; Duthie FR; Grimmond SM; Biankin AV; Wheeler DA; Gibbs RA
Cell Rep; 2016 Feb; 14(4):907-919. PubMed ID: 26804919
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
[TBL] [Abstract][Full Text] [Related]
8. ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.
Archer LK; Frame FM; Walker HF; Droop AP; McDonald GLK; Kucko S; Berney DM; Mann VM; Simms MS; Maitland NJ
FEBS Open Bio; 2022 Jul; 12(7):1365-1387. PubMed ID: 35472129
[TBL] [Abstract][Full Text] [Related]
9. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
10. Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies.
Boti MA; Adamopoulos PG; Tsiakanikas P; Scorilas A
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34072506
[TBL] [Abstract][Full Text] [Related]
11. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Pandey A; Stawiski EW; Durinck S; Gowda H; Goldstein LD; Barbhuiya MA; Schröder MS; Sreenivasamurthy SK; Kim SW; Phalke S; Suryamohan K; Lee K; Chakraborty P; Kode V; Shi X; Chatterjee A; Datta K; Khan AA; Subbannayya T; Wang J; Chaudhuri S; Gupta S; Shrivastav BR; Jaiswal BS; Poojary SS; Bhunia S; Garcia P; Bizama C; Rosa L; Kwon W; Kim H; Han Y; Yadav TD; Ramprasad VL; Chaudhuri A; Modrusan Z; Roa JC; Tiwari PK; Jang JY; Seshagiri S
Nat Commun; 2020 Aug; 11(1):4225. PubMed ID: 32839463
[TBL] [Abstract][Full Text] [Related]
12. Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.
Enfield KSS; Marshall EA; Anderson C; Ng KW; Rahmati S; Xu Z; Fuller M; Milne K; Lu D; Shi R; Rowbotham DA; Becker-Santos DD; Johnson FD; English JC; MacAulay CE; Lam S; Lockwood WW; Chari R; Karsan A; Jurisica I; Lam WL
Nat Commun; 2019 Nov; 10(1):5438. PubMed ID: 31780666
[TBL] [Abstract][Full Text] [Related]
13. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
Luk IY; Reehorst CM; Mariadason JM
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
[TBL] [Abstract][Full Text] [Related]
14. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
Jobling AI; Fang Z; Koleski D; Tymms MJ
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165
[TBL] [Abstract][Full Text] [Related]
15. An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.
Horie M; Tanaka H; Suzuki M; Sato Y; Takata S; Takai E; Miyashita N; Saito A; Nakatani Y; Yachida S
Cancer Sci; 2023 Jun; 114(6):2596-2608. PubMed ID: 36840413
[TBL] [Abstract][Full Text] [Related]
16. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
[TBL] [Abstract][Full Text] [Related]
17. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
18. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer.
Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR; Seth A; Rosenberg M; Papas T; Debouck C; Kola I
Oncogene; 1997 Nov; 15(20):2449-62. PubMed ID: 9395241
[TBL] [Abstract][Full Text] [Related]
19. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter.
Oettgen P; Barcinski M; Boltax J; Stolt P; Akbarali Y; Libermann TA
Genomics; 1999 Feb; 55(3):358-62. PubMed ID: 10049594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
